Literature DB >> 32657013

Heterozygous missense variant in EIF6 gene: A novel form of Shwachman-Diamond syndrome?

Ai Ling Koh1,2, Carine Bonnard3, Jiin Ying Lim1,2, Woei Kang Liew1, Koh Cheng Thoon1,2, Terrence Thomas1,2, Nur Ain Binte Ali3, Alvin Yu Jin Ng4, Sumanty Tohari4, Kong Boo Phua1,2, Byrappa Venkatesh4,5, Bruno Reversade3,4,5, Saumya Shekhar Jamuar1,2,6,7.   

Abstract

Shwachman-Diamond syndrome (SDS) is a rare multisystem ribosomal biogenesis disorder characterized by exocrine pancreatic insufficiency, hematologic abnormalities and bony abnormalities. About 90% of patients have biallelic mutations in SBDS gene. Three additional genes-EFL1, DNAJC21 and SRP54 have been reported in association with a SDS phenotype. However, the cause remains unknown for ~10% of patients. Herein, we report a 6-year-old Chinese boy, who presented in the neonatal period with pancytopenia, liver transaminitis with hepatosplenomegaly and developmental delay, and subsequently developed pancreatic insufficiency complicated by malabsorption and poor growth. Exome sequencing identified a novel de novo heterozygous variant in EIF6 (c.182G>T, p.Arg61Leu). EIF6 protein inhibits ribosomal maturation and is removed in the late steps of ribosomal maturation by SBDS and EFL1 protein. Given the interaction of EIF6 with SBDS and EFL1, we postulate heterozygous variants in EIF6 as a novel cause of Shwachman-Diamond-like phenotype. We compared the phenotype of our patient with those in patients with mutation in SBDS, EFL1, DNAJC21, and SRP54 genes to support this association. Identification of more cases of this novel phenotype would strengthen the association with the genetic etiology.
© 2020 Wiley Periodicals LLC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32657013     DOI: 10.1002/ajmg.a.61758

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Somatic genetic rescue of a germline ribosome assembly defect.

Authors:  Shengjiang Tan; Laëtitia Kermasson; Christine Hilcenko; Vasileios Kargas; David Traynor; Ahmed Z Boukerrou; Norberto Escudero-Urquijo; Alexandre Faille; Alexis Bertrand; Maxim Rossmann; Beatriz Goyenechea; Li Jin; Jonathan Moreil; Olivier Alibeu; Blandine Beaupain; Christine Bôle-Feysot; Stefano Fumagalli; Sophie Kaltenbach; Jean-Alain Martignoles; Cécile Masson; Patrick Nitschké; Mélanie Parisot; Aurore Pouliet; Isabelle Radford-Weiss; Frédéric Tores; Jean-Pierre de Villartay; Mohammed Zarhrate; Ai Ling Koh; Kong Boo Phua; Bruno Reversade; Peter J Bond; Christine Bellanné-Chantelot; Isabelle Callebaut; François Delhommeau; Jean Donadieu; Alan J Warren; Patrick Revy
Journal:  Nat Commun       Date:  2021-08-19       Impact factor: 17.694

2.  Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome.

Authors:  Valentino Bezzerri; Laura Lentini; Martina Api; Elena Marinelli Busilacchi; Vincenzo Cavalieri; Antonella Pomilio; Francesca Diomede; Anna Pegoraro; Simone Cesaro; Antonella Poloni; Andrea Pace; Oriana Trubiani; Giuseppe Lippi; Ivana Pibiri; Marco Cipolli
Journal:  Biomedicines       Date:  2022-04-12

Review 3.  Genetics and genomics of bone marrow failure syndrome.

Authors:  Hyun-Young Kim; Hee-Jin Kim; Sun-Hee Kim
Journal:  Blood Res       Date:  2022-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.